TransMedics Stock 104% Over: Is 2026 the Next Breakout?
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Learn how value tilts steer retirement portfolio index funds toward undervalued opportunities, balancing risk while pursuing higher long-term gains.
25,656 articlesTransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
After a challenging stretch for semiconductor names, intel stock bounced back today. This guide explains the key cata...
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
A landmark listed on the NYSE signals bigger access to capital and greater scrutiny for cannabis companies. Learn how...
As energy demand grows, NuScale Power offers a potential long-term angle with small modular reactors. This guide expl...
Inflation is back in the headlines, and auto insurers feel it first. This guide explains how rising repair costs, use...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
Investors are eyeing AAR's AIR 2026 earnings call for clues on aftermarket demand, margins, and guidance. This articl...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
A fresh wave of legal headlines rattled the markets, pulling down a big‑name hardware stock and lifting caution acros...
ASML and Applied Materials ride an AI-capex wave, but their business models diverge. ASML benefits from EUV pricing p...